In addition to isoliquiritigenin, its derivative, neoisoliquiritigenin, showed a vital inhibitory effect on breast cancer through direct binding to 78-kDa glucose-regulated protein (GRP78), which demonstrated a critical role in mediating tumorigenesis, metastasis and angiogenesis. The gene discussed is HSPA5; the disease is breast cancer.